Kestra Medical Technologies (KMTS) Change in Accured Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Change in Accured Expenses data on file, last reported at $4.0 million in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 112.24% year-over-year to $4.0 million in Q2 2026; TTM through Apr 2026 was $8.2 million, a 77.54% increase from a year earlier, with the FY2026 full-year figure at $8.2 million, up 77.54% from the prior year.
• Change in Accured Expenses for Q2 2026 stood at $4.0 million, up from $3.7 million in the prior quarter.
• Over the last five years, Change in Accured Expenses for KMTS reached as high as $4.0 million in Q2 2026 and fell as low as -$860000.0 in Q3 2025.
• Historically, Change in Accured Expenses has averaged $1.6 million across 3 years, with a median of $1.4 million in 2025.
• Across the five-year window, Change in Accured Expenses slumped 714.29% in 2025 and jumped 288.98% in 2026, its largest moves.
• Year by year, Change in Accured Expenses stood at $1.6 million in 2024, then slipped by 16.16% to $1.4 million in 2025, then soared by 190.22% to $4.0 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $4.0 million in Q2 2026, $3.7 million in Q1 2026, and $1.4 million in Q4 2025.